Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.

Loomans HA, Arnold SA, Hebron K, Taylor CJ, Zijlstra A, Andl CD.

Am J Cancer Res. 2017 Dec 1;7(12):2422-2437. eCollection 2017.

2.

Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal.

Waldemer-Streyer RJ, Reyes-Ordoñez A, Kim D, Zhang R, Singh N, Chen J.

NPJ Regen Med. 2017;2. pii: 16017. doi: 10.1038/npjregenmed.2016.17. Epub 2017 Jan 5.

3.

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.

Seachrist DD, Sizemore ST, Johnson E, Abdul-Karim FW, Weber Bonk KL, Keri RA.

Breast Cancer Res. 2017 Jun 5;19(1):66. doi: 10.1186/s13058-017-0857-y.

4.

A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke.

Lee HT, Liu SP, Lin CH, Lee SW, Hsu CY, Sytwu HK, Hsieh CH, Shyu WC.

Theranostics. 2017 Feb 8;7(4):855-875. doi: 10.7150/thno.17558. eCollection 2017.

5.

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.

FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.

6.

Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.

Antsiferova M, Piwko-Czuchra A, Cangkrama M, Wietecha M, Sahin D, Birkner K, Amann VC, Levesque M, Hohl D, Dummer R, Werner S.

EMBO Mol Med. 2017 Jan;9(1):27-45. doi: 10.15252/emmm.201606493.

7.

The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6.

Lau B, Poole E, Krishna B, Sellart I, Wills MR, Murphy E, Sinclair J.

Sci Rep. 2016 Aug 5;6:31205. doi: 10.1038/srep31205.

8.

CXCL14 as an emerging immune and inflammatory modulator.

Lu J, Chatterjee M, Schmid H, Beck S, Gawaz M.

J Inflamm (Lond). 2016 Jan 5;13:1. doi: 10.1186/s12950-015-0109-9. eCollection 2016. Review.

9.

Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.

Qiu W, Tang SM, Lee S, Turk AT, Sireci AN, Qiu A, Rose C, Xie C, Kitajewski J, Wen HJ, Crawford HC, Sims PA, Hruban RH, Remotti HE, Su GH.

Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.

10.

Inhibins tune the thymocyte selection process by regulating thymic stromal cell differentiation.

Carbajal-Franco E, de la Fuente-Granada M, Alemán-Muench GR, García-Zepeda EA, Soldevila G.

J Immunol Res. 2015;2015:837859. doi: 10.1155/2015/837859. Epub 2015 Apr 20.

11.

The immunoregulatory and fibrotic roles of activin A in allergic asthma.

Hardy CL, Rolland JM, O'Hehir RE.

Clin Exp Allergy. 2015 Oct;45(10):1510-22. doi: 10.1111/cea.12561. Review.

12.

Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.

Fowler TW, Kamalakar A, Akel NS, Kurten RC, Suva LJ, Gaddy D.

J Cell Sci. 2015 Feb 15;128(4):683-94. doi: 10.1242/jcs.157834. Epub 2015 Jan 20.

13.

Contribution of corneal neovascularization to dendritic cell migration into the central area during human corneal infection.

Narumi M, Kashiwagi Y, Namba H, Ohe R, Yamakawa M, Yamashita H.

PLoS One. 2014 Oct 9;9(10):e109859. doi: 10.1371/journal.pone.0109859. eCollection 2014.

14.

Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.

Maeshima A, Mishima K, Yamashita S, Nakasatomi M, Miya M, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K, Hasegawa Y, Kojima I, Nojima Y.

Biomed Res Int. 2014;2014:376191. doi: 10.1155/2014/376191. Epub 2014 May 5.

15.

Circulating conventional and plasmacytoid dendritic cell subsets display distinct kinetics during in vivo repeated allergen skin challenges in atopic subjects.

Vittorakis S, Samitas K, Tousa S, Zervas E, Aggelakopoulou M, Semitekolou M, Panoutsakopoulou V, Xanthou G, Gaga M.

Biomed Res Int. 2014;2014:231036. doi: 10.1155/2014/231036. Epub 2014 Apr 28.

16.

Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway.

Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, Musso T, Tabbia G, Bardessono M, Pasquali C, Mantovani A, Sozzani S, Bosisio D.

PLoS One. 2013 Dec 30;8(12):e82867. doi: 10.1371/journal.pone.0082867. eCollection 2013.

17.

Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues.

Alexeev V, Donahue A, Uitto J, Igoucheva O.

Cytotherapy. 2013 Feb;15(2):171-184.e1. doi: 10.1016/j.jcyt.2012.11.006.

18.

Distinct transcriptional signatures of bone marrow-derived C57BL/6 and DBA/2 dendritic leucocytes hosting live Leishmania amazonensis amastigotes.

Giraud E, Lecoeur H, Soubigou G, Coppée JY, Milon G, Prina E, Lang T.

PLoS Negl Trop Dis. 2012;6(12):e1980. doi: 10.1371/journal.pntd.0001980. Epub 2012 Dec 13.

19.

CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study.

Zhong W, Chen W, Zhang D, Sun J, Li Y, Zhang J, Gao Y, Zhou W, Li S.

Exp Ther Med. 2012 Sep;4(3):363-369. Epub 2012 Jul 4.

20.

Antimicrobial activities of chemokines: not just a side-effect?

Wolf M, Moser B.

Front Immunol. 2012 Jul 23;3:213. doi: 10.3389/fimmu.2012.00213. eCollection 2012.

Supplemental Content

Support Center